This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ahmed, S. F. Articles by Hughes, I. A. Search for Related Content PubMed PubMed Citation Articles by Ahmed, S. F. Articles by Hughes, I. A.

Phenotypic Features, Androgen Receptor Binding, and Mutational Analysis in 278 Clinical Cases Reported as Androgen Insensitivity Syndrome¹

Department of Paediatrics, University of Cambridge Clinical School, Cambridge CB2 2QQ, United Kingdom

Address correspondence and requests for reprints to: Dr. S. Faisal Ahmed, Department of Paediatrics, University of Cambridge Clinical School, Box 166, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom. E-mail: sfa21{at}cam.ac.uk

Androgen insensitivity syndrome (AIS) is the most common single entity that results in male under-masculinization, but large cohort studies of AIS have rarely been performed. Over the last decade, nationwide cooperation between pediatric endocrinologists in the United Kingdom has allowed the creation of a database of cases of intersex and ambiguous genitalia where detailed clinical information on every notified case has been collected via a questionnaire. Among the 816 entries recorded by January 1999, there were 105 clinically diagnosed cases of complete AIS (CAIS) and 173 cases of partial AIS (PAIS). A masculinization score was devised by scoring the external phenotype, and a score of 12 represented normal masculinization. Androgen receptor (AR) binding was determined by studying binding capacity (B_max) and receptor affinity (K_d), and cases were classified as either zero, abnormal, or normal binding. Mutation screening of all eight exons of the AR gene was performed by single-strand conformational polymorphism analysis, followed by direct DNA sequencing.

All cases of PAIS presented within the first month of birth. The median age at presentation of children with CAIS was 1 yr (P10,P90:0.1,10.4). The testes were palpable in the labioscrotal folds or the inguinal region in 77% and 41% of cases of CAIS and PAIS, respectively. There was marked overlap between the masculinization score of those children with PAIS reared as girls [2.5(P10,P90:1, 6)] and those reared as boys [3(P10,P90:2, 7.5)]. Gonadectomy was performed prepubertally in 66% and postpubertally in 29% of the cases of CAIS. The median age of the latter group was older at 14 yr (P10,P90:0.1,18). No cases of malignancy or carcinoma in situ were reported in the 121 cases of AIS where histology results were available. Biochemical endocrine investigations were reported to have been performed in a greater number of cases of PAIS than CAIS (98% vs. 48%). AR binding was abnormal in 44 of 51 (86%) and 40 of 113 (35%) cases of CAIS and PAIS, respectively. Zero binding was encountered in 29 of 43 (67%) and 1 of 55 (2%) cases of CAIS and PAIS, respectively. Mutational analysis of the AR gene, performed in 102 index cases was positive in 57 of 69 (83%) cases of CAIS and 12 of 43 (28%) cases of PAIS. In 24 of these cases, the mutation identified was novel. The mutations in PAIS cases were all missense, whereas in CAIS the mutations were more diverse. AR binding was only normal in 3 of 69 mutation-positive cases. In the PAIS group, mutation-positive cases had a significantly higher K_d and B_max compared to the mutation negative cases.

The clinical diagnosis of AIS can be confirmed in a significant number of cases by a combination of androgen-binding studies and mutational analysis. There is some correlation between the phenotypic features and the abnormalities discovered on mutational analysis of the AR gene, but there is a need to improve this further by developing optimal bioassays of AR function. The phenotypic heterogeneity among clinically diagnosed cases of AIS emphasizes the need for appropriate comprehensive evaluation of male under-masculinization.

This article has been cited by other articles:

				M. B. Cox, D. L. Riggs, M. Hessling, F. Schumacher, J. Buchner, and D. F. Smith FK506-Binding Protein 52 Phosphorylation: A Potential Mechanism for Regulating Steroid Hormone Receptor Activity Mol. Endocrinol., December 1, 2007; 21(12): 2956 - 2967. [Abstract] [Full Text] [PDF]

				R. Coutant, D. Mallet, N. Lahlou, N. Bouhours-Nouet, A. Guichet, L. Coupris, A. Croue, and Y. Morel Heterozygous Mutation of Steroidogenic Factor-1 in 46,XY Subjects May Mimic Partial Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2868 - 2873. [Abstract] [Full Text] [PDF]

				C. Bouvattier, B. Mignot, H. Lefevre, Y. Morel, and P. Bougneres Impaired Sexual Activity in Male Adults with Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3310 - 3315. [Abstract] [Full Text] [PDF]

				M. Cools, S. L. S. Drop, K. P. Wolffenbuttel, J. W. Oosterhuis, and L. H. J. Looijenga Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers Endocr. Rev., August 1, 2006; 27(5): 468 - 484. [Abstract] [Full Text] [PDF]

				C. P. Houk, I. A. Hughes, S. F. Ahmed, P. A. Lee, and Writing Committee for the International Intersex C Summary of Consensus Statement on Intersex Disorders and Their Management Pediatrics, August 1, 2006; 118(2): 753 - 757. [Full Text] [PDF]

				P. A. Lee, C. P. Houk, S. F. Ahmed, I. A. Hughes, and in collaboration with the participants in the Inte Consensus Statement on Management of Intersex Disorders Pediatrics, August 1, 2006; 118(2): e488 - e500. [Full Text] [PDF]

				I A Hughes, C Houk, S F Ahmed, P A Lee, and LWPES/ESPE Consensus Group Consensus statement on management of intersex disorders Arch. Dis. Child., July 1, 2006; 91(7): 554 - 563. [Full Text] [PDF]

				J Jaaskelainen, A Deeb, J W Schwabe, N P Mongan, H Martin, and I A Hughes Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains. J. Mol. Endocrinol., April 1, 2006; 36(2): 361 - 368. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, and C. Y. Bowers Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition Endocr. Rev., April 1, 2006; 27(2): 101 - 140. [Abstract] [Full Text] [PDF]

				B. He, R. T. Gampe Jr., A. T. Hnat, J. L. Faggart, J. T. Minges, F. S. French, and E. M. Wilson Probing the Functional Link between Androgen Receptor Coactivator and Ligand-binding Sites in Prostate Cancer and Androgen Insensitivity J. Biol. Chem., March 10, 2006; 281(10): 6648 - 6663. [Abstract] [Full Text] [PDF]

				J. Cheung-Flynn, V. Prapapanich, M. B. Cox, D. L. Riggs, C. Suarez-Quian, and D. F. Smith Physiological Role for the Cochaperone FKBP52 in Androgen Receptor Signaling Mol. Endocrinol., June 1, 2005; 19(6): 1654 - 1666. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, A. Bae, R. S. Swerdloff, A. Iranmanesh, and C. Wang Experimentally Induced Androgen Depletion Accentuates Ethnicity-Related Contrasts in Luteinizing Hormone Secretion in Asian and Caucasian Men J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1632 - 1638. [Abstract] [Full Text] [PDF]

				A. Umar, C. A. Berrevoets, N. M. Van, M. van Leeuwen, M. Verbiest, W. J. Kleijer, D. Dooijes, J. A. Grootegoed, S. L. S. Drop, and A. O. Brinkmann Functional Analysis of a Novel Androgen Receptor Mutation, Q902K, in an Individual with Partial Androgen Insensitivity J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 507 - 515. [Abstract] [Full Text] [PDF]

				S. E. Hannema, I. S. Scott, J. Hodapp, H. Martin, N. Coleman, J. W. Schwabe, and I. A. Hughes Residual Activity of Mutant Androgen Receptors Explains Wolffian Duct Development in the Complete Androgen Insensitivity Syndrome J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5815 - 5822. [Abstract] [Full Text] [PDF]

				Y. A. Elhaji, J. Hui Wu, B. Gottlieb, L. K. Beitel, C. Alvarado, G. Batist, and M. A. Trifiro An Examination of How Different Mutations at Arginine 855 of the Androgen Receptor Result in Different Androgen Insensitivity Phenotypes Mol. Endocrinol., August 1, 2004; 18(8): 1876 - 1886. [Abstract] [Full Text] [PDF]

				K. F. S. Melo, B. B. Mendonca, A. E. C. Billerbeck, E. M. F. Costa, M. Inacio, F. A. Q. Silva, A. M. O. Leal, A. C. Latronico, and I. J. P. Arnhold Clinical, Hormonal, Behavioral, and Genetic Characteristics of Androgen Insensitivity Syndrome in a Brazilian Cohort: Five Novel Mutations in the Androgen Receptor Gene J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3241 - 3250. [Abstract] [Full Text] [PDF]

				G.-Z. Liu, H. Wang, and Z. Wang Identification of a Highly Conserved Domain in the Androgen Receptor That Suppresses the DNA-binding Domain-DNA Interactions J. Biol. Chem., April 18, 2003; 278(17): 14956 - 14960. [Abstract] [Full Text] [PDF]

				G. Liao, L.-Y. Chen, A. Zhang, A. Godavarthy, F. Xia, J. C. Ghosh, H. Li, and J. D. Chen Regulation of Androgen Receptor Activity by the Nuclear Receptor Corepressor SMRT J. Biol. Chem., February 7, 2003; 278(7): 5052 - 5061. [Abstract] [Full Text] [PDF]

				S. Rosa, A. Biason-Lauber, N. P. Mongan, F. Navratil, and E. J. Schoenle Complete Androgen Insensitivity Syndrome Caused by a Novel Mutation in the Ligand-Binding Domain of the Androgen Receptor: Functional Characterization J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4378 - 4382. [Abstract] [Full Text] [PDF]

				C. A. Heinlein and C. Chang Androgen Receptor (AR) Coregulators: An Overview Endocr. Rev., April 1, 2002; 23(2): 175 - 200. [Abstract] [Full Text] [PDF]

				N. P. Mongan, J. Jaaskelainen, K. Green, J. W. Schwabe, N. Shimura, M. Dattani, and I. A. Hughes Two de Novo Mutations in the AR Gene Cause the Complete Androgen Insensitivity Syndrome in a Pair of Monozygotic Twins J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1057 - 1061. [Abstract] [Full Text] [PDF]

				M. P. Longnecker, M. A. Klebanoff, J. W. Brock, H. Zhou, K. A. Gray, L. L. Needham, and A. J. Wilcox Maternal Serum Level of 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and Risk of Cryptorchidism, Hypospadias, and Polythelia among Male Offspring Am. J. Epidemiol., February 15, 2002; 155(4): 313 - 322. [Abstract] [Full Text] [PDF]

				C. Bouvattier, J.-C. Carel, C. Lecointre, A. David, C. Sultan, A.-M. Bertrand, Y. Morel, and J.-L. Chaussain Postnatal Changes of T, LH, and FSH in 46,XY Infants with Mutations in the AR Gene J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 29 - 32. [Abstract] [Full Text] [PDF]

				M. K. Gupta, D. H. Geller, and R. J. Auchus Pitfalls in Characterizing P450c17 Mutations Associated with Isolated 17,20-Lyase Deficiency J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4416 - 4423. [Abstract] [Full Text] [PDF]

				I. A. Hughes Minireview: Sex Differentiation Endocrinology, August 1, 2001; 142(8): 3281 - 3287. [Abstract] [Full Text] [PDF]

				H. N. Lim, R. M. Nixon, H. Chen, I. A. Hughes, and J. R. Hawkins Evidence That Longer Androgen Receptor Polyglutamine Repeats Are a Causal Factor for Genital Abnormalities J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3207 - 3210. [Abstract] [Full Text] [PDF]

				A. Lindqvist, I. A. Hughes, and S. Andersson Substitution Mutation C268Y Causes 17{beta}-Hydroxysteroid Dehydrogenase 3 Deficiency J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 921 - 923. [Abstract] [Full Text]

				M. Tomboc, P. A. Lee, M. F. Mitwally, F. X. Schneck, M. Bellinger, and S. F. Witchel Insulin-like 3/Relaxin-Like Factor Gene Mutations Are Associated with Cryptorchidism J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4013 - 4018. [Abstract] [Full Text]

				I. A. Hughes A Novel Explanation for Resistance to Androgens N. Engl. J. Med., September 21, 2000; 343(12): 880 - 882. [Full Text]